JATT Acquisition (JATT) Competitors $1.12 +0.07 (+6.67%) As of 07/2/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsTrendsBuy This Stock JATT vs. ZURA, CLLS, XBIT, PLRX, PYXS, QNTM, VNRX, OKYO, EPIX, and ABOSShould you be buying JATT Acquisition stock or one of its competitors? The main competitors of JATT Acquisition include Zura Bio (ZURA), Cellectis (CLLS), XBiotech (XBIT), Pliant Therapeutics (PLRX), Pyxis Oncology (PYXS), Quantum Biopharma (QNTM), VolitionRx (VNRX), OKYO Pharma (OKYO), ESSA Pharma (EPIX), and Acumen Pharmaceuticals (ABOS). These companies are all part of the "pharmaceutical products" industry. JATT Acquisition vs. Its Competitors Zura Bio Cellectis XBiotech Pliant Therapeutics Pyxis Oncology Quantum Biopharma VolitionRx OKYO Pharma ESSA Pharma Acumen Pharmaceuticals JATT Acquisition (NYSE:JATT) and Zura Bio (NASDAQ:ZURA) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, institutional ownership, dividends, risk, earnings, media sentiment and valuation. Which has preferable valuation & earnings, JATT or ZURA? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioJATT AcquisitionN/AN/A$6.85MN/AN/AZura BioN/AN/A-$45.39M-$0.70-1.62 Is JATT or ZURA more profitable? Zura Bio's return on equity of -42.84% beat JATT Acquisition's return on equity.Company Net Margins Return on Equity Return on Assets JATT AcquisitionN/A -49.58% 2.84% Zura Bio N/A -42.84%-35.22% Does the media refer more to JATT or ZURA? In the previous week, Zura Bio had 1 more articles in the media than JATT Acquisition. MarketBeat recorded 1 mentions for Zura Bio and 0 mentions for JATT Acquisition. Zura Bio's average media sentiment score of 1.71 beat JATT Acquisition's score of 0.00 indicating that Zura Bio is being referred to more favorably in the news media. Company Overall Sentiment JATT Acquisition Neutral Zura Bio Very Positive Do analysts prefer JATT or ZURA? Zura Bio has a consensus target price of $14.33, indicating a potential upside of 1,161.74%. Given Zura Bio's stronger consensus rating and higher possible upside, analysts clearly believe Zura Bio is more favorable than JATT Acquisition.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score JATT Acquisition 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Zura Bio 0 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 1 Strong Buy rating(s) 3.13 Do insiders and institutionals believe in JATT or ZURA? 48.0% of JATT Acquisition shares are held by institutional investors. Comparatively, 61.1% of Zura Bio shares are held by institutional investors. 20.0% of JATT Acquisition shares are held by company insiders. Comparatively, 14.2% of Zura Bio shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. SummaryZura Bio beats JATT Acquisition on 8 of the 11 factors compared between the two stocks. Get JATT Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for JATT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding JATT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart JATT vs. The Competition Export to ExcelMetricJATT AcquisitionBiological Products IndustryMedical SectorNYSE ExchangeMarket Cap$19.32M$204.24M$5.53B$20.55BDividend YieldN/AN/A5.38%3.75%P/E RatioN/AN/A27.4028.05Price / SalesN/A223.65419.6045.87Price / Cash27.0822.4436.6322.31Price / Book-2.115.618.084.59Net Income$6.85M-$96.61M$3.16B$985.44M7 Day Performance-2.61%-0.56%2.84%2.78%1 Month Performance4.67%-0.93%3.69%5.40%1 Year Performance-68.09%16.18%35.30%14.61% JATT Acquisition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)JATTJATT AcquisitionN/A$1.12+6.7%N/A-67.3%$19.32MN/A0.003High Trading VolumeZURAZura Bio3.3318 of 5 stars$1.18-2.5%$14.33+1,114.7%-67.6%$82.73MN/A-1.693CLLSCellectis2.5398 of 5 stars$1.50+2.0%$4.00+166.7%-22.7%$81.71M$49.22M-1.74290XBITXBiotech0.5087 of 5 stars$2.66-0.4%N/A-45.3%$81.40M$4.01M-2.06100PLRXPliant Therapeutics4.0005 of 5 stars$1.38+6.2%$13.31+864.7%-88.2%$79.80M$1.58M-0.3890PYXSPyxis Oncology1.2755 of 5 stars$1.28flat$9.00+603.1%-61.3%$79.29M$16.15M-0.8160News CoveragePositive NewsQNTMQuantum BiopharmaN/A$24.37-10.2%N/AN/A$78.88MN/A-1.52N/AVNRXVolitionRx1.6944 of 5 stars$0.76-1.5%$3.50+360.5%+22.5%$78.30M$1.31M-2.1180OKYOOKYO Pharma1.9058 of 5 stars$2.47+7.4%$7.00+183.4%+145.8%$77.82MN/A0.007Gap DownEPIXESSA Pharma1.3367 of 5 stars$1.74+0.6%$2.00+14.9%-64.1%$76.79MN/A-2.7650News CoverageABOSAcumen Pharmaceuticals1.3065 of 5 stars$1.23-2.4%$6.33+414.9%-50.8%$76.32MN/A-0.6320Positive News Related Companies and Tools Related Companies ZURA Alternatives CLLS Alternatives XBIT Alternatives PLRX Alternatives PYXS Alternatives QNTM Alternatives VNRX Alternatives OKYO Alternatives EPIX Alternatives ABOS Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:JATT) was last updated on 7/4/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredWhy Is President Trump Fast-Tracking These Companies?Forget about AI… There's a hot new trend on Wall Street… and it's all thanks to President Trump. His administr...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding JATT Acquisition Corp Please log in to your account or sign up in order to add this asset to your watchlist. Share JATT Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free JATT Stock Alerts